Literature DB >> 15194222

Both BRAF and KRAS mutations are rare in colorectal carcinomas from patients with hereditary nonpolyposis colorectal cancer.

Michiko Miyaki1, Takeru Iijima, Tatsuro Yamaguchi, Tsuyoki Kadofuku, Nobuaki Funata, Takeo Mori.   

Abstract

The BRAF mutations have been suggested to be linked with defective mismatch repair in colorectal carcinomas. To clarify the extent of BRAF mutations in HNPCC colorectal carcinomas, which are typical mismatch repair deficient carcinomas, we compared the frequency of BRAF mutations between HNPCC, familial adenomatous polyposis (FAP) and sporadic cases. The frequency of KRAS mutations was also compared between these three syndromes. No BRAF mutations were detected in 33 HNPCC colorectal carcinomas, while they were detected in 3 of 26 (12%) FAP carcinomas and 2 of 53 (4%) microsatellite stable sporadic carcinomas. KRAS mutations were detected in 2 of 33 (6%) HNPCC, 9 of 26 (35%) FAP and 18 of 53 (34%) sporadic carcinomas. Such extremely low frequencies of BRAF and KRAS mutations in HNPCC colorectal carcinomas suggest that the participation of RAS-RAF signaling is minor in HNPCC, and that the previously suggested high frequency of BRAF mutations in mismatch repair deficient colorectal carcinomas is not due to mutations of mismatch repair genes. Copyright 2004 Elsevier Ireland Ltd.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194222     DOI: 10.1016/j.canlet.2004.01.027

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  Serrated adenomas with a BRAF mutation in a young patient with familial adenomatous polyposis.

Authors:  Kentaro Moriichi; Hiroki Tanabe; Yusuke Ono; Yu Kobayashi; Yuki Murakami; Takuya Iwama; Takehito Kunogi; Takahiro Sasaki; Keitaro Takahashi; Katsuyoshi Ando; Nobuhiro Ueno; Shin Kashima; Hidehiro Takei; Yusuke Mizukami; Mikihiro Fujiya; Toshikatsu Okumura
Journal:  Int J Colorectal Dis       Date:  2020-06-05       Impact factor: 2.571

2.  Differences in histological features and PD-L1 expression between sporadic microsatellite instability and Lynch-syndrome-associated disease in Japanese patients with colorectal cancer.

Authors:  Rin Yamada; Tatsuro Yamaguchi; Takeru Iijima; Rika Wakaume; Misato Takao; Koichi Koizumi; Tsunekazu Hishima; Shin-Ichiro Horiguchi
Journal:  Int J Clin Oncol       Date:  2018-01-11       Impact factor: 3.402

Review 3.  Complementary analysis of microsatellite tumor profile and mismatch repair defects in colorectal carcinomas.

Authors:  Alfredo Blanes; Salvador J Diaz-Cano
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

4.  Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.

Authors:  M B Loughrey; P M Waring; A Tan; M Trivett; S Kovalenko; V Beshay; M-A Young; G McArthur; A Boussioutas; A Dobrovic
Journal:  Fam Cancer       Date:  2007-04-24       Impact factor: 2.375

5.  Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing.

Authors:  Allison M Cushman-Vokoun; Daniel G Stover; Zhiguo Zhao; Elizabeth A Koehler; Jordan D Berlin; Cindy L Vnencak-Jones
Journal:  Clin Colorectal Cancer       Date:  2013-06-14       Impact factor: 4.481

6.  Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer.

Authors:  Amy J French; Daniel J Sargent; Lawrence J Burgart; Nathan R Foster; Brian F Kabat; Richard Goldberg; Lois Shepherd; Harold E Windschitl; Stephen N Thibodeau
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

7.  BRAF mutations are associated with distinctive clinical, pathological and molecular features of colorectal cancer independently of microsatellite instability status.

Authors:  Wei Qi Li; Kazuyuki Kawakami; Andrew Ruszkiewicz; Graeme Bennett; James Moore; Barry Iacopetta
Journal:  Mol Cancer       Date:  2006-01-10       Impact factor: 27.401

Review 8.  Does the Microbiota Composition Influence the Efficacy of Colorectal Cancer Immunotherapy?

Authors:  Yan Lin; De-Xia Kong; You-Ni Zhang
Journal:  Front Oncol       Date:  2022-04-08       Impact factor: 5.738

Review 9.  A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory.

Authors:  Margot G F van Lier; Anja Wagner; Monique E van Leerdam; Katharina Biermann; Ernst J Kuipers; Ewout W Steyerberg; Hendrikus Jan Dubbink; Winand N M Dinjens
Journal:  J Cell Mol Med       Date:  2009-11-19       Impact factor: 5.310

10.  Lack of BRAFV600E mutation in stage I and II of colorectal cancer.

Authors:  Mahsa Molaei; Roya Kishani Farahani; Mina Maftouh; Mohammad Yaghoob Taleghani; Mahsa Vahdatinia; Fatemeh Khatami; Ehsan Nazemalhosseini-Mojarad; Hamid Asadzadeh Aghdae; Akram Aboutorabi; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.